IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,027 | +10.6% | 199 | 0.0% | 0.00% | – |
| Q2 2023 | $8,165 | +135.5% | 199 | +105.2% | 0.00% | – |
| Q1 2023 | $3,467 | +9023.7% | 97 | +9600.0% | 0.00% | – |
| Q4 2022 | $38 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | -92.9% | 0.00% | – |
| Q3 2021 | $0 | – | 14 | +1300.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -98.4% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 63 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 63 | +6200.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
| Q4 2019 | $21,000 | +40.0% | 351 | +42.7% | 0.00% | – |
| Q3 2019 | $15,000 | -6.2% | 246 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -20.0% | 246 | +0.4% | 0.00% | – |
| Q1 2019 | $20,000 | -41.2% | 245 | -61.6% | 0.00% | -100.0% |
| Q4 2018 | $34,000 | +161.5% | 638 | +159.3% | 0.00% | – |
| Q3 2018 | $13,000 | -59.4% | 246 | -67.9% | 0.00% | -100.0% |
| Q2 2018 | $32,000 | -44.8% | 766 | -42.2% | 0.00% | 0.0% |
| Q1 2018 | $58,000 | -6.5% | 1,325 | +7.7% | 0.00% | 0.0% |
| Q4 2017 | $62,000 | 0.0% | 1,230 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $62,000 | +10.7% | 1,230 | +11.8% | 0.00% | 0.0% |
| Q2 2017 | $56,000 | +1766.7% | 1,100 | +1386.5% | 0.00% | – |
| Q1 2017 | $3,000 | -40.0% | 74 | -26.0% | 0.00% | – |
| Q4 2016 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -66.7% | 100 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |